title: Letter by Taqueti and Bhatt Regarding Article, "Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study".
authors.affiliation: From Brigham and Women's Hospital, Heart and Vascular Center (V.R.T., D.L.B.), and Cardiovascular Imaging Program, Departments of Medicine (Cardiology) and Radiology (Nuclear Medicine) (V.R.T.), Harvard Medical School, Boston, MA.
authors.forename: Viviany R
authors.initials: VR
authors.lastname: Taqueti
authors.affiliation: From Brigham and Women's Hospital, Heart and Vascular Center (V.R.T., D.L.B.), and Cardiovascular Imaging Program, Departments of Medicine (Cardiology) and Radiology (Nuclear Medicine) (V.R.T.), Harvard Medical School, Boston, MA.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
mesh_terms: D001241:Aspirin; D004359:Drug Therapy, Combination; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin